{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:56:04Z","timestamp":1777931764240,"version":"3.51.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00223-020-00688-1","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T02:02:12Z","timestamp":1586224932000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Medications as a Risk Factor for Fragility Hip Fractures: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"107","author":[{"given":"Sharri J.","family":"Mortensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Mohamadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy J.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"von Keudell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ara","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"issue":"5","key":"688_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3109\/14397595.2013.866921","volume":"24","author":"A Nishimura","year":"2014","unstructured":"Nishimura A, Akeda K, Kato K et al (2014) Osteoporosis, vertebral fractures and mortality in a Japanese rural community. Mod Rheumatol 24(5):840\u2013843","journal-title":"Mod Rheumatol"},{"issue":"1","key":"688_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mayocp.2014.09.011","volume":"90","author":"A Singer","year":"2015","unstructured":"Singer A, Exuzides A, Spangler L et al (2015) Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc 90(1):53\u201362","journal-title":"Mayo Clin Proc"},{"issue":"970","key":"688_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/pgmj.2005.044370","volume":"82","author":"EW Peng","year":"2006","unstructured":"Peng EW, Elnikety S, Hatrick NC (2006) Preventing fragility hip fracture in high risk groups: an opportunity missed. Postgrad Med J 82(970):528\u2013531","journal-title":"Postgrad Med J"},{"issue":"14","key":"688_CR4","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.2009.1462","volume":"302","author":"CA Brauer","year":"2009","unstructured":"Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302(14):1573\u20131579","journal-title":"JAMA"},{"issue":"8","key":"688_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00198-004-1592-7","volume":"15","author":"DS Zingmond","year":"2004","unstructured":"Zingmond DS, Melton LJ 3rd, Silverman SL (2004) Increasing hip fracture incidence in California Hispanics, 1983 to 2000. Osteoporos Int 15(8):603\u2013610","journal-title":"Osteoporos Int"},{"issue":"3","key":"688_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2106\/JBJS.I.00919","volume":"92","author":"A Unnanuntana","year":"2010","unstructured":"Unnanuntana A, Gladnick BP, Donnelly E, Lane JM (2010) The assessment of fracture risk. J Bone Joint Surg Am 92(3):743\u2013753","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"688_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1535-7597.2003.03104.x","volume":"3","author":"HP Goodkin","year":"2003","unstructured":"Goodkin HP, Kapur J (2003) Responsiveness of status Epilepticus to treatment with Diazepan decreases rapidly as seizure duration increases. Epilepsy Curr 3(1):11\u201312","journal-title":"Epilepsy Curr"},{"issue":"3","key":"688_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jvs.2015.04.389","volume":"62","author":"J Walker","year":"2015","unstructured":"Walker J, Tucker LY, Goodney P et al (2015) Type II endoleak with or without intervention after endovascular aortic aneurysm repair does not change aneurysm-related outcomes despite sac growth. J Vasc Surg 62(3):551\u2013561","journal-title":"J Vasc Surg"},{"issue":"4","key":"688_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s002239900431","volume":"62","author":"Y Adachi","year":"1998","unstructured":"Adachi Y, Shiota E, Matsumata T, Iso Y, Yoh R, Kitano S (1998) Bone mineral density in patients taking H2-receptor antagonist. Calcif Tissue Int 62(4):283\u2013285","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"688_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","volume":"128","author":"PB Burns","year":"2011","unstructured":"Burns PB, Rohrich RJ, Chung KC (2011) The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 128(1):305\u2013310","journal-title":"Plast Reconstr Surg"},{"issue":"15","key":"688_CR11","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.2106\/JBJS.17.01239","volume":"100","author":"A Mohamadi","year":"2018","unstructured":"Mohamadi A, Chan JJ, Lian J et al (2018) Risk factors and pooled rate of prolonged opioid use following trauma or surgery: a systematic review and meta-(regression) analysis. J Bone Joint Surg Am 100(15):1332\u20131340","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"688_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088\u20131101","journal-title":"Biometrics"},{"key":"688_CR13","doi-asserted-by":"publisher","first-page":"i3365","DOI":"10.1136\/bmj.i3365","volume":"353","author":"B Abrahamsen","year":"2016","unstructured":"Abrahamsen B, Eiken P, Prieto-Alhambra D, Eastell R (2016) Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study. BMJ 353:i3365","journal-title":"BMJ"},{"issue":"11","key":"688_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annepidem.2015.08.010","volume":"25","author":"AL Adams","year":"2015","unstructured":"Adams AL, Shi JXM, Reynolds K et al (2015) Statins and hip fracture risk in men: a population-based case-control study. Ann Epidemiol 25(11):844\u2013848","journal-title":"Ann Epidemiol"},{"issue":"5","key":"688_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.bone.2011.07.035","volume":"49","author":"EM Apalset","year":"2011","unstructured":"Apalset EM, Gjesdal CG, Eide GE, Tell GS (2011) Intake of vitamin K1 and K2 and risk of hip fractures: the Hordaland Health Study. Bone 49(5):990\u2013995","journal-title":"Bone"},{"issue":"7","key":"688_CR16","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00198-010-1455-3","volume":"22","author":"MEL Arbouw","year":"2011","unstructured":"Arbouw MEL, Movig KLL, van Staa TP, Egberts ACG, Souverein PC, de Vries F (2011) Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporos Int 22(7):2197\u20132204","journal-title":"Osteoporos Int"},{"issue":"2","key":"688_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00198-012-2053-3","volume":"24","author":"SD Berry","year":"2013","unstructured":"Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y (2013) Diuretic initiation and the acute risk of hip fracture. Osteoporos Int 24(2):689\u2013695","journal-title":"Osteoporos Int"},{"issue":"8","key":"688_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/JGP.0b013e31817c6a99","volume":"16","author":"CM Chang","year":"2008","unstructured":"Chang CM, Wu EC, Chang IS, Lin KM (2008) Benzodiazepine and risk of hip fractures in older people: a nested case-control study in Taiwan. Am J Geriatr Psychiatry 16(8):686\u2013692","journal-title":"Am J Geriatr Psychiatry"},{"issue":"11","key":"688_CR19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/pds.2026","volume":"19","author":"HF Chiu","year":"2010","unstructured":"Chiu HF, Huang YW, Chang CC, Yang CY (2010) Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf 19(11):1131\u20131136","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"688_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/j.gastro.2010.03.055","volume":"139","author":"DA Corley","year":"2010","unstructured":"Corley DA, Kubo A, Zhao W, Quesenberry C (2010) Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 139(1):93\u2013101","journal-title":"Gastroenterology"},{"issue":"1","key":"688_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF01623465","volume":"7","author":"D Feskanich","year":"1997","unstructured":"Feskanich D, Willett WC, Stampfer MJ, Colditz GA (1997) A prospective study of thiazide use and fractures in women. Osteoporos Int 7(1):79\u201384","journal-title":"Osteoporos Int"},{"issue":"1","key":"688_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF03167722","volume":"170","author":"P Fitzpatrick","year":"2001","unstructured":"Fitzpatrick P, Kirke PN, Daly L et al (2001) Predictors of first hip fracture and mortality post fracture in older women. Ir J Med Sci 170(1):49\u201353","journal-title":"Ir J Med Sci"},{"issue":"12","key":"688_CR23","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s001980070022","volume":"11","author":"KM Fox","year":"2000","unstructured":"Fox KM, Cummings SR, Williams E, Stone K (2000) Femoral neck and intertrochanteric fractures have different risk factors: a prospective study. Osteoporos Int. 11(12):1018\u20131023","journal-title":"Osteoporos Int."},{"issue":"9","key":"688_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/oxfordjournals.aje.a009171","volume":"145","author":"JA Grisso","year":"1997","unstructured":"Grisso JA, Kelsey JL, O'Brien LA et al (1997) Risk factors for hip fracture in men. Hip Fracture Study Group. Am J Epidemiol 145(9):786\u2013793","journal-title":"Am J Epidemiol"},{"issue":"10","key":"688_CR25","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/oxfordjournals.aje.a009933","volume":"150","author":"S Hoidrup","year":"1999","unstructured":"Hoidrup S, Gronbaek M, Pedersen AT, Lauritzen JB, Gottschau A, Schroll M (1999) Hormone replacement therapy and hip fracture risk: effect modification by tobacco smoking, alcohol intake, physical activity, and body mass index. Am J Epidemiol 150(10):1085\u20131093","journal-title":"Am J Epidemiol"},{"issue":"1","key":"688_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-115-1-1","volume":"115","author":"FE Heidrich","year":"1991","unstructured":"Heidrich FE, Stergachis A, Gross KM (1991) Diuretic drug use and the risk for hip fracture. Ann Intern Med 115(1):1\u20136","journal-title":"Ann Intern Med"},{"issue":"6","key":"688_CR27","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.bone.2005.07.005","volume":"37","author":"GW Hugenholtz","year":"2005","unstructured":"Hugenholtz GW, Heerdink ER, van Staa TP, Nolen WA, Egberts AC (2005) Risk of hip\/femur fractures in patients using antipsychotics. Bone 37(6):864\u2013870","journal-title":"Bone"},{"issue":"8","key":"688_CR28","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s00198-010-1446-4","volume":"22","author":"HF Hwang","year":"2011","unstructured":"Hwang HF, Lee HD, Huang HH, Chen CY, Lin MR (2011) Fall mechanisms, bone strength, and hip fractures in elderly men and women in Taiwan. Osteoporos Int 22(8):2385\u20132393","journal-title":"Osteoporos Int"},{"issue":"4","key":"688_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00001648-199807000-00012","volume":"9","author":"H Jacqmin-Gadda","year":"1998","unstructured":"Jacqmin-Gadda H, Fourrier A, Commenges D, Dartigues JF (1998) Risk factors for fractures in the elderly. Epidemiology 9(4):417\u2013423","journal-title":"Epidemiology"},{"issue":"2","key":"688_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2105\/AJPH.71.2.138","volume":"71","author":"RE Johnson","year":"1981","unstructured":"Johnson RE, Specht EE (1981) The risk of hip fracture in postmenopausal females with or without estrogen drug exposure. Am J Public Health 71(2):138\u2013144","journal-title":"Am J Public Health"},{"issue":"1","key":"688_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5603\/ARM.2017.0005","volume":"85","author":"A Karakatsani","year":"2017","unstructured":"Karakatsani A, Katsoulis M, Klinaki E, Trichopoulou A (2017) Corticosteroids and hip fracture risk in elderly respiratory patients: EPIC-Greece cohort. Adv Respir Med 85(1):22\u201327","journal-title":"Adv Respir Med"},{"issue":"7288","key":"688_CR32","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/bmj.322.7288.704","volume":"322","author":"C Pierfitte","year":"2001","unstructured":"Pierfitte C, Macouillard G, Thicoipe M et al (2001) Benzodiazepines and hip fractures in elderly people: case-control study. BMJ 322(7288):704\u2013708","journal-title":"BMJ"},{"issue":"9","key":"688_CR33","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00198-008-0826-5","volume":"20","author":"S Pouwels","year":"2009","unstructured":"Pouwels S, van Staa TP, Egberts AC, Leufkens HG, Cooper C, de Vries F (2009) Antipsychotic use and the risk of hip\/femur fracture: a population-based case-control study. Osteoporos Int 20(9):1499\u20131506","journal-title":"Osteoporos Int"},{"issue":"3","key":"688_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00198-010-1337-8","volume":"22","author":"S Pouwels","year":"2011","unstructured":"Pouwels S, Lalmohamed A, Souverein P et al (2011) Use of proton pump inhibitors and risk of hip\/femur fracture: a population-based case-control study. Osteoporos Int 22(3):903\u2013910","journal-title":"Osteoporos Int"},{"issue":"6","key":"688_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00198-003-1568-z","volume":"15","author":"L Rejnmark","year":"2004","unstructured":"Rejnmark L, Olsen ML, Johnsen SP, Vestergaard P, Sorensen HT, Mosekilde L (2004) Hip fracture risk in statin users\u2013a population-based Danish case-control study. Osteoporos Int 15(6):452\u2013458","journal-title":"Osteoporos Int"},{"issue":"3","key":"688_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00223-004-0084-2","volume":"76","author":"L Rejnmark","year":"2005","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76(3):167\u2013175","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"688_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","volume":"259","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Fracture risk in patients treated with loop diuretics. J Intern Med 259(1):117\u2013124","journal-title":"J Intern Med"},{"issue":"20","key":"688_CR38","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.298.20.2389","volume":"298","author":"J Robbins","year":"2007","unstructured":"Robbins J, Aragaki AK, Kooperberg C et al (2007) Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 298(20):2389\u20132398","journal-title":"JAMA"},{"issue":"1","key":"688_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1164\/rccm.200305-640OC","volume":"169","author":"S Suissa","year":"2004","unstructured":"Suissa S, Baltzan M, Kremer R, Ernst P (2004) Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 169(1):83\u201388","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"688_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12603-016-0679-0","volume":"20","author":"HW Thaler","year":"2016","unstructured":"Thaler HW, Sterke CS, van der Cammen TJM (2016) Association of proton pump inhibitor use with recurrent falls and risk of fractures in older women: a study of medication use in older fallers. J Nutr Health Aging 20(1):77\u201381","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"688_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/PL00004174","volume":"11","author":"AM Tromp","year":"2000","unstructured":"Tromp AM, Ooms ME, Popp-Snijders C, Roos JC, Lips P (2000) Predictors of fractures in elderly women. Osteoporos Int 11(2):134\u2013140","journal-title":"Osteoporos Int"},{"issue":"5","key":"688_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1365-2796.2003.01219.x","volume":"254","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard P, Olsen ML, Paaske Johnsen S, Rejnmark L, Sorensen HT, Mosekilde L (2003) Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark. J Intern Med 254(5):486\u2013493","journal-title":"J Intern Med"},{"issue":"6","key":"688_CR43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","volume":"17","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17(6):807\u2013816","journal-title":"Osteoporos Int"},{"issue":"3","key":"688_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00223-007-9065-6","volume":"81","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int 81(3):153\u2013161","journal-title":"Calcif Tissue Int"},{"issue":"24","key":"688_CR45","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1001\/jama.283.24.3211","volume":"283","author":"PS Wang","year":"2000","unstructured":"Wang PS, Solomon DH, Mogun H, Avorn J (2000) HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283(24):3211\u20133216","journal-title":"JAMA"},{"issue":"11","key":"688_CR46","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1177\/1060028014545038","volume":"48","author":"IM Ward","year":"2014","unstructured":"Ward IM, Mortensen EM, Battafarano DF, Frei CR, Mansi I (2014) Association of statins and risk of fractures in a military health system: a propensity score-matched analysis. Ann Pharmacother 48(11):1406\u20131414","journal-title":"Ann Pharmacother"},{"issue":"3","key":"688_CR47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/eurpub\/7.3.335","volume":"7","author":"SK Weiland","year":"1997","unstructured":"Weiland SK, R\u00fcckmann A, Keil U, Lewis M, Dennler HJ, Welzel D (1997) Thiazide diuretics and the risk of hip fracture among 70\u201379 year old women treated for hypertension. Eur J Pub Health 7(3):335\u2013340","journal-title":"Eur J Pub Health"},{"issue":"24","key":"688_CR48","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","volume":"296","author":"YX Yang","year":"2006","unstructured":"Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA J Am Med Assoc 296(24):2947\u20132953","journal-title":"JAMA J Am Med Assoc"},{"issue":"4","key":"688_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00223-008-9170-1","volume":"83","author":"EW Yu","year":"2008","unstructured":"Yu EW, Blackwell T, Ensrud KE et al (2008) Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int 83(4):251\u2013259","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"688_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/154099903321154112","volume":"12","author":"SK Van Den Eeden","year":"2003","unstructured":"Van Den Eeden SK, Barzilay JI, Ettinger B, Minkoff J (2003) Thyroid hormone use and the risk of hip fracture in women %3e or = 65 years: a case-control study. J Women's Health 12(1):27\u201331","journal-title":"J Women's Health"},{"issue":"8","key":"688_CR51","doi-asserted-by":"publisher","first-page":"e105376","DOI":"10.1371\/journal.pone.0105376","volume":"9","author":"JW Jackson","year":"2014","unstructured":"Jackson JW, Schneeweiss S, VanderWeele TJ, Blacker D (2014) Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis. PLoS ONE 9(8):e105376","journal-title":"PLoS ONE"},{"issue":"6","key":"688_CR52","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4088\/JCP.12r08064","volume":"74","author":"J Nielsen","year":"2013","unstructured":"Nielsen J, Correll CU, Manu P, Kane JM (2013) Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided? J Clin Psychiatry. 74(6):603\u2013613","journal-title":"J Clin Psychiatry."},{"issue":"9","key":"688_CR53","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1365-2850.2009.01472.x","volume":"16","author":"B Stubbs","year":"2009","unstructured":"Stubbs B (2009) Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density. J Psychiatr Ment Health Nurs 16(9):838\u2013842","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"1","key":"688_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4306\/pi.2016.13.1.89","volume":"13","author":"DR Milovanovic","year":"2016","unstructured":"Milovanovic DR, Stanojevic Pirkovic M, Zivancevic Simonovic S et al (2016) Parameters of calcium metabolism fluctuated during initiation or changing of antipsychotic drugs. Psychiatry Investig 13(1):89\u2013101","journal-title":"Psychiatry Investig"},{"issue":"6","key":"688_CR55","first-page":"8893","volume":"8","author":"D Cai","year":"2015","unstructured":"Cai D, Feng W, Jiang Q (2015) Acid-suppressive medications and risk of fracture: an updated meta-analysis. Int J Clin Exp Med 8(6):8893\u20138904","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"688_CR56","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/EDE.0b013e318294bec6","volume":"24","author":"L Cea-Soriano","year":"2013","unstructured":"Cea-Soriano L, Johansson S, Garcia Rodriguez LA (2013) Risk factors for falls with use of acid-suppressive drugs. Epidemiology 24(4):600\u2013607","journal-title":"Epidemiology"},{"key":"688_CR57","unstructured":"U.S. FADA (2010) FDA Drug Safety Communication: possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fda-drug-safety-communication-possible-increased-risk-fractures-hip-wrist-and-spine-use-proton-pump. Accessed 10 June 2019"},{"issue":"7","key":"688_CR58","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00198-018-4486-9","volume":"29","author":"X Xiao","year":"2018","unstructured":"Xiao X, Xu Y, Wu Q (2018) Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies. Osteoporos Int 29(7):1515\u20131524","journal-title":"Osteoporos Int"},{"issue":"15","key":"688_CR59","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1056\/NEJM197104152841506","volume":"284","author":"CG Duarte","year":"1971","unstructured":"Duarte CG, Winnacker JL, Becker KL, Pace A (1971) Thiazide-induced hypercalcemia. N Engl J Med 284(15):828\u2013830","journal-title":"N Engl J Med"},{"issue":"3","key":"688_CR60","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/8756-3282(95)00486-6","volume":"18","author":"TR Arnett","year":"1996","unstructured":"Arnett TR, Spowage M (1996) Modulation of the resorptive activity of rat osteoclasts by small changes in extracellular pH near the physiological range. Bone 18(3):277\u2013279","journal-title":"Bone"},{"issue":"5","key":"688_CR61","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1532-5415.1993.tb01887.x","volume":"41","author":"CA Peh","year":"1993","unstructured":"Peh CA, Horowitz M, Wishart JM, Need AG, Morris HA, Nordin BE (1993) The effect of chlorothiazide on bone-related biochemical variables in normal post-menopausal women. J Am Geriatr Soc 41(5):513\u2013516","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"688_CR62","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1359\/jbmr.2000.15.5.894","volume":"15","author":"D Lajeunesse","year":"2000","unstructured":"Lajeunesse D, Delalandre A, Guggino SE (2000) Thiazide diuretics affect osteocalcin production in human osteoblasts at the transcription level without affecting vitamin D3 receptors. J Bone Miner Res 15(5):894\u2013901","journal-title":"J Bone Miner Res"},{"issue":"5","key":"688_CR63","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/ki.1996.461","volume":"50","author":"R Aubin","year":"1996","unstructured":"Aubin R, Menard P, Lajeunesse D (1996) Selective effect of thiazides on the human osteoblast-like cell line MG-63. Kidney Int 50(5):1476\u20131482","journal-title":"Kidney Int"},{"issue":"8","key":"688_CR64","first-page":"472","volume":"50","author":"T Jenkinson","year":"1993","unstructured":"Jenkinson T, Bhalla AK (1993) A reappraisal of steroid-induced osteoporosis. Br J Hosp Med 50(8):472\u2013476","journal-title":"Br J Hosp Med"},{"issue":"8","key":"688_CR65","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2165\/00002018-200124080-00005","volume":"24","author":"JD Adachi","year":"2001","unstructured":"Adachi JD, Papaioannou A (2001) Corticosteroid-Induced osteoporosis: detection and management. Drug Saf 24(8):607\u2013624","journal-title":"Drug Saf"},{"issue":"9","key":"688_CR66","first-page":"2222","volume":"27","author":"R McKenzie","year":"2000","unstructured":"McKenzie R, Reynolds JC, O'Fallon A et al (2000) Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. J Rheumatol 27(9):2222\u20132226","journal-title":"J Rheumatol"},{"issue":"4","key":"688_CR67","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160(4):526\u2013534","journal-title":"Arch Intern Med"},{"issue":"3","key":"688_CR68","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2265.2004.02053.x","volume":"61","author":"E Murphy","year":"2004","unstructured":"Murphy E, Williams GR (2004) The thyroid and the skeleton. Clin Endocrinol 61(3):285\u2013298","journal-title":"Clin Endocrinol"},{"issue":"10","key":"688_CR69","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1359\/jbmr.2003.18.10.1795","volume":"18","author":"LD Carbone","year":"2003","unstructured":"Carbone LD, Tylavsky FA, Cauley JA et al (2003) Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. J Bone Miner Res 18(10):1795\u20131802","journal-title":"J Bone Miner Res"},{"issue":"1","key":"688_CR70","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jbmr.5650110106","volume":"11","author":"DC Bauer","year":"1996","unstructured":"Bauer DC, Orwoll ES, Fox KM et al (1996) Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11(1):29\u201335","journal-title":"J Bone Miner Res"},{"issue":"4","key":"688_CR71","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00198-011-1692-0","volume":"23","author":"P Vestergaard","year":"2012","unstructured":"Vestergaard P, Hermann P, Jensen JE, Eiken P, Mosekilde L (2012) Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int 23(4):1255\u20131265","journal-title":"Osteoporos Int"},{"issue":"3","key":"688_CR72","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/jbmr.3616","volume":"34","author":"JM Hughes","year":"2019","unstructured":"Hughes JM, McKinnon CJ, Taylor KM et al (2019) Nonsteroidal anti-inflammatory drug prescriptions are associated with increased stress fracture diagnosis in the US army population. J Bone Miner Res 34(3):429\u2013436","journal-title":"J Bone Miner Res"},{"issue":"7115","key":"688_CR73","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","volume":"315","author":"PA Rochon","year":"1997","unstructured":"Rochon PA, Gurwitz JH (1997) Optimising drug treatment for elderly people: the prescribing cascade. BMJ 315(7115):1096\u20131099","journal-title":"BMJ"},{"issue":"4","key":"688_CR74","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385\u2013397","journal-title":"Osteoporos Int"},{"issue":"4","key":"688_CR75","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bone.2007.07.008","volume":"41","author":"ML Bianchi","year":"2007","unstructured":"Bianchi ML (2007) Osteoporosis in children and adolescents. Bone 41(4):486\u2013495","journal-title":"Bone"},{"issue":"11","key":"688_CR76","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/01.MIB.0000188341.96726.15","volume":"11","author":"FA Sylvester","year":"2005","unstructured":"Sylvester FA (2005) IBD and skeletal health: children are not small adults! Inflamm Bowel Dis 11(11):1020\u20131023","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"688_CR77","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00198-012-2030-x","volume":"23","author":"S Ferrari","year":"2012","unstructured":"Ferrari S, Bianchi ML, Eisman JA et al (2012) Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 23(12):2735\u20132748","journal-title":"Osteoporos Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-020-00688-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T23:12:39Z","timestamp":1617750759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-020-00688-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00688-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}